#CDMOWeek
Day 4 of #CDMOWeek 🧬

Juggling vector design, optimization & manufacturing? 😵‍💫

VectorBuilder helps you do it all, end to end 🚀
From vector design to GMP, all in one place (no chaos).

Talk to the CliniVec™ team today for a free consultation!
April 30, 2026 at 9:42 AM
For day three of our #CDMOWeek, we’re sharing a recent article from the @nytimes.com highlighting how our customers at Neion Bio are rethinking biologics manufacturing, developing chicken-based systems that aims to use eggs as platforms for drug production.

www.nytimes.com/2026/03/26/s...
How to Turn a Chicken Egg Into a Drug Factory
www.nytimes.com
April 29, 2026 at 5:18 PM
It's Day 2 of #CDMOWeek!

Meet the VectorBuilder team at #ISCT2026 in Dublin, Ireland! Be sure to stop by Booth 1905 to learn how VectorBuilder is supporting cell and gene therapy development and translational research from our latest array of products and services.
April 28, 2026 at 3:38 PM
It’s day 1 of #CDMOWeek 🧬

VectorBuilder is a full-service CDMO supporting every stage of gene therapy—from vector design to GMP manufacturing and QC.

Hear from our Head of CDMO Operations, Dr. Alan Griffith, on how we can support your pipeline 👇
April 27, 2026 at 2:37 PM
Wrapping up #CDMOWeek with a quick stroll through some of VectorBuilder’s GMP Facilities! 🏭🔬

👉 Swipe through for a mini tour!

Learn more here: www.vectorbuilder.com/gmp-manufact...
April 4, 2025 at 3:58 PM
Day 3 of #CDMOWeek! 🚀🔬

Say hello to miniVec™, VectorBuilder’s innovative, miniaturized backbone that's designed for high-yield, endotoxin-free plasmid DNA production, and supports antibiotic-free and supplement-free selection!

💻 Watch Our miniVec™ Webinar: www.youtube.com/watch?v=qPpk...
April 2, 2025 at 5:40 PM
Day 2 of #CDMOWeek! 🚀 Looking to streamline your cell and gene therapy manufacturing? Our latest CDMO solutions flyer breaks down how VectorBuilder accelerates your journey from concept to clinic.

📩 Download now: en.vectorbuilder.com/resources/br...

#CDMO #GeneTherapy #VectorManufacturing #CGT
April 1, 2025 at 4:49 PM